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Context: Controversy exists on the effect of obesity on bone development during puberty.
Objective:Our objective was to determine differences in volumetric bonemineral density (vBMD)
andbonegeometry inmale obese adolescents (ObAs) in overlapwith changes in bonematuration,
muscle mass and force development, and circulating sex steroids and IGF-I. We hypothesized that
changes inboneparameters aremoreevidentat theweight-bearing site and that changes in serum
estradiol are most prominent.
Design, Setting, and Participants: We recruited 51 male ObAs (10–19 years) at the entry of a
residential weight-loss program and 51 healthy age-matched and 51 bone-age–matched controls.
Main Outcome Measures: vBMD and geometric bone parameters, as well as muscle and fat area
were studied at the forearm and lower leg by peripheral quantitative computed tomography.
Muscle force was studied by jumping mechanography.
Results: In addition to an advanced bone maturation, differences in trabecular bone parameters
(higher vBMD and larger trabecular area) and cortical bone geometry (larger cortical area and
periosteal and endosteal circumference) were observed in ObAs both at the radius and tibia at
different pubertal stages. After matching for bone age, all differences at the tibia, but only the
difference in trabecular vBMD at the radius, remained significant. Larger muscle area and higher
maximal force were found in ObAs compared with controls, as well as higher circulating free
estrogen, but similar free testosterone and IGF-I levels.
Conclusions:ObAshave largerand strongerbonesatboth the forearmand lower leg. Theobserved
differences in bone parameters can be explained by a combination of advanced bonematuration,
higherestrogenexposure,andgreatermechanical loadingresultingfromahighermusclemassand
strength. (J Clin Endocrinol Metab 98: 3019–3028, 2013)
Childhood and adolescence are critical periods in thedevelopment of optimal bone strength because a low
peak bone mass achieved in early adulthood is a risk for
osteoporosis later in life. The most crucial stage in bone
mass acquisition is puberty; skeletal mass approximately
doubles between the start and the end of adolescence
(1, 2). Conditions that alter bone development during this
particular maturational period may lead to suboptimal
bone strength and higher fracture risk (2).
Given the rising prevalence and severity of obesity in
adolescenceand the increasing evidence thatoverweight in
adolescence may contribute to skeletal fractures (3–5), it
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is essential to understand the effects of obesity on bone
development. Some studies report higher areal bone min-
eral density (aBMD) in overweight children (6), whereas
others conclude that obesity is linked toa lower aBMD(7).
An important limitation of these dual-energy x-ray ab-
sorptiometry studies is the size dependence of the aBMD
and the lack of data on bone geometry. Prediction of bone
strength requires knowledge of both the material (eg, vol-
umetric BMD [vBMD]) and geometric properties of bone
(eg, size and shape) (8). Therefore, peripheral quantitative
computed tomography (pQCT) is a useful approach in
bone strength analysis because it can provide 3-dimen-
sional information about BMD, size, and shape (9).
Literature on the effects of adiposity and obesity on
vBMD and bone size in children is scarce (10–12) with
conflicting results. In prepubertal children, there is some
evidence that fat mass may have a positive effect on bone,
whereas fat mass has a negative effect on bone during
puberty and immediately after puberty (13–16).
Main determinants of pubertal bone mass accumula-
tion and changes in bone geometry are sex steroids, the
GH–IGF-I axis, and muscle mass and strength. Sex ste-
roids and the GH–IGF-I axis have a role not only in stim-
ulating bone growth but also in muscle mass accrual in
adolescents (1). Muscle strength strongly stimulates the
acquisition of bone mass by exerting strain on the bone
surface (9). The interactions of loading, IGF-I and sex
steroids are held responsible for the development of skel-
etal gender dimorphism, leading to greater bone size, peri-
osteal expansion, and bone strength in adolescent boys
(17, 18). There is some evidence from studies in prepu-
bertal children and adolescents that obese subjects have a
higher muscle mass (11) and disturbed sex steroid and
IGF-I levels (19, 20).
Becausemechanical and hormonal determinants (espe-
cially estradiol [E2]) are important in bone mass acquisi-
tion inmale adolescents by their effects onbone expansion
and bone mineralization, this study aims to determine the
changes in vBMD as well as geometry of long bones by
pQCT inmale obese adolescents (ObAs) by studying non–
weight-bearing (radius) as well as a weight-bearing (tibia)
sites. Moreover, it also aims to investigate potential dis-
turbances in muscle strength and specific hormonal pa-
rameters, such as sex steroids and IGF-I, known to influ-
ence bone mineralization and bone expansion during
adolescence. We hypothesized that in ObAs, changes in
bone parameters would be more evident at the weight-
bearing site and that changes in serum E2 would be most
prominent.
Subjects and Methods
Subjects
Fifty-onemaleObAs (bodymass index [BMI] SD score [SDS]
 2) aged 10 to 19 years were investigated at the entry of a
residential weight-loss program in July 2011 at the Zeepreven-
torium in De Haan, Belgium. Fifty-one age-matched (maximal
difference of 6 months) and body height-matched (maximal dif-
ference of 5 cm) as well as 51 bone age-matched (maximal dif-
ference of 6 months) and body height-matched (maximal differ-
ence of 5 cm) healthy normal-weight controls were selected
blindly from an ongoing longitudinal study evaluating changes
in bone geometry and muscle strength in relation to sex steroids
in childhood and adolescence. These healthy children were re-
cruited by letters distributed in several schools within the Ghent
area. Obese and control subjects were not related to each other.
Neither was there any relatedness between the control subjects.
Obese and control children were excluded if they were taking
medication known to influence bone or mineral metabolism in
the past year or if they had a metabolic bone disease, thyroid
disorder, or diabetes. Both study protocolswere approved by the
Ethical Committee of the Ghent University Hospital. Informed
consent was obtained from the parents, and all participants gave
their assent.
Methods
Anthropometry
Informationaboutmedical history, lifestyle, physical activity,
and socioeconomic background was collected through a ques-
tionnaire. Standing height was measured to the nearest 0.1 cm
using a Harpenden stadiometer (Holtain Ltd, Crymuch, United
Kingdom). Body weight was measured in light indoor clothing
without shoes to thenearest 0.5kg.Waist circumference, defined
as the smallest abdominal circumference if present or otherwise
measured halfway between the iliac crest and the rib cage, was
determined to the nearest 0.1 cm. All anthropometric measure-
ments were performed by the same trained physician. The SDS
for body height, weight, and BMI was computed using the ref-
erence data of the 2004 Flemish growth study (21). Pubertal
status of the subjects was assessed by the same trained physician
according to the method established by Tanner (Tanner genital
staging: stage 1, prepuberty; stage 5, postpuberty).
Bone age determination
Bone age reading of an x-ray of the left hand and wrist was
done by 2 independent readers (2 pediatric radiologists), both
blinded for the chronological age, using the Greulich and Pyle
method (22), and the mean of both readings was taken. If the
differencewasmore than 1 year, a third independent reading (by
a trained pediatrician)was performed and the 2 closest estimates
were retained. Skeletal age differences (SAD) were calculated by
subtracting the chronological age (CA) from the skeletal age (SA)
(SAD SA CA), with positive differences reflecting an accel-
erated skeletal maturation and negative differences a delayed
bone maturation.
Peripheral quantitative computed tomography
Bone variables, estimates of bone strength, and regional body
composition of the forearm and the lower leg were measured
using pQCT (StratecXCT-2000, version 6; StratecMedizintech-
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nik,Germany). The scannerwas positioned on the nondominant
forearm (radius) and lower leg (tibia). Two 2.0-mm slices (voxel
size 0.5mm)weremeasured at the 4%and 66%sites proximally
from the distal end of the radius and 2 slices at the 4% and 38%
site proximally from the endof the tibia. The cross-sectional area
(CSA)of the radius/tibiawasdeterminedafterdetecting theouter
bone contour at a threshold of 280 mg/cm3. For determining
cortical vBMD, the thresholdwas set at 710mg/cm3,whereas for
trabecular bone, it was set at 180 mg/cm3. The cortical vBMD
(mg/cm3), cortical CSA (mm2), muscle and fat CSA, endosteal
andperiosteal circumferences (mm), and cortical thickness (mm)
were measured at the midradius (66% of bone length from the
distal end) andmidshaft tibia (38%ofbone length fromthedistal
end). The combined CSA ofmuscle and bone (fibula and tibia or
radius and ulna) was determined at a threshold of 40 mg/cm3,
and the bone CSA was determined with the threshold set at 280
mg/cm3. Muscle CSA was calculated by subtracting the bone
CSA from the combined muscle and bone CSA. Fat CSA was
calculated by subtracting the combined muscle and bone CSA
from the total CSA. The strength-strain index (SSI) of the radius
66% and the tibia 38%was calculated (23). To assess the SSI, a
threshold of 480mg/cm3 was used. Trabecular vBMD (mg/cm3)
and area were measured using a scan through the distal metaph-
ysis at the radius and the tibia (at 4% of bone length). The CSA
of the radius/tibia was determined after detecting the outer mar-
gin; 55% of this cross-sectional bone area was peeled off to
separate trabecular bone from the cortical shell. The coefficient
of variation (CV) for the calibration phantom was1% as cal-
culated form daily phantom measurements.
Jumping mechanography
Allmeasurementswere recordedwith theLeonardoMechanogra-
phyGroundReactionForcePlatform(NovotecMedicalGmbH,Pfor-
zheim, Germany). Both the multiple 1-legged hopping and the single
2-legged jump were analyzed using the Leonardo Mechanography
GRFP Research Edition software version 4.2-b05.46d. The multiple
1-leggedhoppingrepresents1-leggedhoppingonthe forefootwith the
aim to achieve amaximal ground reaction force. It evaluates themax-
imal force towhich the tibia is exposed and thus can serve to evaluate
the muscle-bone unit. The maximal force and the maximal force rel-
ative to body mass of the left and the right leg were analyzed for this
hop. The single 2-legged jump is a vertical countermovement jump to
achievemaximum jump height. Parameters of this particular analysis
were jump height, peak velocity, maximal force, maximal force/body
mass,maximalpeakpower,andmaximalpeakpower/bodymass(24).
Eachsubjectperformed3single2-leggedjumps,andtherecordingwith
the highest jump height was selected. For the multiple 1-legged hop-
ping,aminimumof10accuratejumpshadtobeperformedoneachleg.
All tests were performed between 10:00 AM and 3:00 PM by the same
observer using the same device. All subjects were fed and had exerted
normal daily activity before the test.
Hormonal measurements
Venous blood samples in the obese group were obtained be-
tween 8:00 and 10:00 AM after overnight fasting. Blood samples
in the age- and height-matched control group were collected
between 8:00 and 10:00 AM after a small breakfast (25). All
samples were stored at80°C until batch analysis. Commercial
immunoassays were used to measure serum IGF-I (Diagnostic
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Figure 1. A, Mean bone age at different ages in ObAs compared with their age-matched controls. The line plots present mean bone age for each age group
from 11 until 19 years for the 2 study groups. The error bars represent 1 SEM. The obese group is presented by the dashed line and the control group (age
matched controls) by the solid line. The interconnecting lines do not present longitudinal data. B–D, E1 (B), E2 (C), and testosterone (D) in ObAs and their age-
matched controls at different pubertal stages. The line plots present median E1 levels, median E2 levels, andmedian testosterone levels for each pubertal stage
(prepuberty, 1; postpuberty, 5) for the 2 study groups. Because the hormonal data do not meet the criteria for a normal distribution, data are presented as
medians and the error bars represent 95th confidence interval. The obese group is presented by the dashed line and the control group (agematched controls) by
the solid line. The interconnecting lines do not present longitudinal data.
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Systems Laboratories, Webster, Texas), leptin (Linco Research
Inc, St Charles, Missouri), and SHBG (Modular, Roche Diag-
nostics,Mannheim, Germany). The intra- and interassay CV for
all assays were less than 10%. Estradiol (E2), estrone (E1), and
testosteronewere determined by liquid chromatography tandem
mass spectrometry (AB Sciex 5500 triple-quadrupole mass spec-
trometer; AB Sciex, Toronto Canada). Serum limit of quantifi-
cation was 0.5 pg/mL (1.9 pmol/L) for E2 and E1, and the
interassay CV were 4.0% at 21 pg/mL (77 pmol/L) for E2 and
7.6% at 25 pg/mL (93 pmol/L) for E1 (26). Serum limit of quan-
tification was 1.2 ng/dL for testosterone, and the interassay CV
were 8.3% at 36.7 ng/dL and 3.1% at 307.8 ng/dL. Free testos-
terone was determined by equilibrium dialysis (27), and free
estradiol was calculated from total E2, SHBG, and albumin con-
centrations using a previously validated equation derived from
the mass action law (28).
Statistics
Normality was checked using quantile-quantile plots and Sha-
piro-Wilk tests. Data are presented as mean  SD or as medians
(25th75th percentile) in case of a non-normal distribution. Com-
parisons between obese and control groups were performed using
parametric independent t tests or ANOVA, when criteria for nor-
mality were met. In other cases, Mann-WhitneyU tests were used.
Between-group differences of categorical variables were calculated
Table 1. Comparison of Anthropometric Data and Measures of Regional Body Composition Between Obese Boys
and Age and Bone-Age–Matched Control Boysa
  
 Obese boys 
(mean ± SD) 
Age-matched 
Controls  
(mean ± SD)  
Bone age- matched 
Controls      
(mean ± SD) 
Signiﬁcance  
Age-matched  
(p) 
Signiﬁcance 
Bone-age matched  
(p)    
Anthropometry    
Age (y) 14.4 ± 2.3 14.4 ± 2.3 15.0 ± 2.0 NS NS
Bone age (y) 15.5 ± 2.3 14.6 ± 2.7 15.4 ±2.5 .07 NS
Diﬀerence  bone 
age- age (y) 
1.12 ± 0.90  0.18 ± 0.90 -0.36 ±1.0 <.001 <.001
Height (cm) 167.6 ± 11 166.3 ± 11.3 168.7 ± 10.5 NS NS
Height sds 0.29 ± 1.25 0.17± 0.89 -0.04 ± 0.9 NS NS
Weight (kg) 99.4 ± 24.0 53.4 ± 12.4 57.7 ± 11.9 <.001 <.001
Weight sds 2.74 ± 0.59 -0.05 ± 0.77 0.06 ± 0.8 <.001 <.001
BMI (kg/m²) 35.0 ± 5.7 19.0 ± 2.5 19.5 ± 2.5 <.001 <.001
BMI sds 2.55 ± 0.37  -0.18 ± 0.89 -0.36 ± 1.0 <.001 <.001
Waist 
circumference 
(cm) 
102 ± 11 68 ± 6 71  ± 6 <.001 <.001
    
Body composion    
Proximal forearm    
Fat CSA (cm²)  2660 ± 817 683 ± 380 709 ± 388 <.001 <.001
Muscle CSA (cm²)  3106 ± 840 2673 ± 799 2969 ± 799 <.01 NS
Fat/Muscle rao 91  ± 31.9 29 ± 20.8 27 ± 19.2 <.001 <.001
Proximal bia      
Fat CSA (cm²)  4402 ± 1426 1574 ± 498 1656 ± 580 <.001 <.001
Muscle CSA (cm²) 3737 ± 776 3213 ± 850 3429 ± 735 <.01 <.05
Fat/Muscle rao 121 ± 41 51 ± 21 51 ± 22 <.001
 
<.001
Tanner genital  
stage 
Obese boys 
(frequency) 
 
Age-Matched 
Controls  
(frequency) 
 
Bone-age matched
Controls 
(frequency) 
 
G1 11.8% 9.8% 3.9 % NS (chi-square test) NS
G2 17.6% 15.7% 7.8 %  
G3 11.7% 15.7% 17.6 %  
G4 33.3% 33.3% 37.3%  
G5 25.5% 25.5% 33.3%  
a Results are shown as mean  SD or percent. Comparisons between obese and control groups were performed using parametric independent t
tests. Between-group differences of categorical variables were calculated using 2 tests.
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with 2 tests. The independent predictors of the various bone
parameters were tested using linear regression analysis in-
cluding age, BMI, and estrogen levels. The difference was
considered statistically significant atP .05. In Figure 1A, the
following age categories were used: children between 11 and
12 years were categorized as 11 years, children between 12
and 13 years were categorized as 12 years, etc. No rounded
ages were used in the other statistical analyses. Data were
analyzed using SPSS software version 19.0.
Results
Comparison of anthropometric data and regional
body composition analysis by pQCT
Groups matched for chronological age and height
AsshowninTable1,notonlychronologicalageandbody
height but also pubertal stage were comparable between the
2 groups, whereas body weight (SDS) and BMI (SDS) of the
obese group were almost double (P  .001). Moreover,
ObAs had a significantly greater waist circumference (P 
.001). A higher absolute fat CSA, fat to muscle CSA ratio,
and muscle CSA at both tibia and forearm (P  .01) were
observed in the obese boys (Table 1). There was no signifi-
cant difference in mean chronological age and bone age be-
tween both groups. However, there was a significantly ad-
vanced bone maturation in the obese group (P  .001).
Figure1Ashowsanadvancedbonematurationpresentup to
the age of 16 years.
Groups matched for bone age and height
Although body weight SDS (2.69; P  .001), BMI SDS
(2.47;P .001),andwaistcircumference(31cm;P .001)
were significantly different between obese and control group,
no significant difference could be found in bone age (0.1 year;
P .8), height SDS (0.29; P .13), chronological age (0.6
year;P .2),orpubertalstagedistribution(P1,12%vs4%;P2,
18% vs 8%; P3,12% vs 18%; P4, 33% vs 37%; P5, 26% vs
33%, P .27).
Comparison of bone parameters at the upper and
lower limb using pQCT radius
Groups matched for chronological age and height
ObAs have a higher trabecular vBMD (7%) and a
larger trabecular area (10%) at the distal radius. At the
proximal site, cortical area ( 9%), periosteal circumfer-
ence (6%), endosteal circumference (6%), and SSI
(13%) were significantly larger in the obese group (Ta-
ble 2).However, therewas no difference in cortical vBMD
and cortical thickness between the groups. Figure 2 shows
higher values of trabecular vBMD, trabecular area, peri-
osteal circumference, and cortical area at the different pu-
bertal stages in the obese group.
Table 2. Comparison of Volumetric Bone Parameters as Measured by pQCT at the Distal (Trabecular Parameters)
and Proximal Radius (Cortical Parameters) and Distal (Trabecular Parameters) and Proximal Tibia (Cortical Parameters)
Between Obese Boys and Controls Matched for Age and Height and Controls Matched for Bone Age and Heighta
Obese Boys
Controls Significance (P)
Age-Matched Bone-Age–Matched Age-Matched Bone-Age–Matched
Radius
4% measurement site
Trabecular vBMD, mg/cm3 215  33 199  35 201  33 .02 .05
Trabecular area, mm2 157  26 141  33 149  33 .01 NS
66% measurement site
Cortical vBMD, mg/cm3 1001  54 999  55 1006  56 NS NS
Cortical area, mm2 74  19 67  17 71  16 .05 NS
Periosteal circumference, mm 47  4.8 44  4.3 46  4.6 .05 NS
Endosteal circumference, mm 35  4.9 33  6.0 35  4.9 .05 NS
Cortical thickness, mm 1.8  0.4 1.7  0.4 1.8  0.4 NS NS
SSI, mm3 295  94 258  81 281  85 .05 NS
Tibia
4% measurement site
Trabecular vBMD, mg/cm3 239  28 225  34 225  33 .05 .05
Trabecular area, mm2 545  88 463  79 474  76 .001 .001
38% measurement site
Cortical vBMD, mg/cm3 1079  37 1080  54 1093  52 NS NS
Cortical area, mm2 310  60 264  46 272  39 .001 .001
Periosteal circumference, mm 82  9.0 73  6.7 74  8 .001 .001
Endosteal circumference, mm 53  8.2 45  6.4 46  10 .001 .001
Cortical thickness, mm 4.6  0.6 4.4  0.6 4.5  0.5 NS NS
SSI, mm3 1809  467 1424  342 1497  325 .001 .001
a Results are shown as mean  SD. Comparisons between obese and control groups were performed using parametric independent t test.
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Groups matched for bone age and height
ObAs still had a higher trabecular vBMD (6.5%) in
comparison with bone-age–matched controls, but there
was no difference anymore in trabecular area at the distal
end. Moreover, at the proximal site, cortical parameters
were comparable (Table 2).
Tibia
Groups matched for chronological age and height
As shown in Table 2, trabecular vBMD (6%) and area
(15%) at the tibia were significantly higher in the obese
group. At the midshaft, tibial cortical area (15%), perios-
teal circumference (11%), and en-
dosteal circumference (15%) were
larger in the obese group (P  .001).
The SSI was also significantly higher
(21%) in the obese group. Figure 3
showsclearlya largercorticalareaand
periosteal circumference at the differ-
entpubertal stages.Additionally, both
trabecular vBMD and area were
higher in the obese group, whereas
there was no significant difference in
cortical vBMD and cortical thickness
between the 2 groups.
Groups matched for bone age
and height
Matching for bone age gave sim-
ilar results; the trabecular vBMD
(6%) and area (13%) measured
at the distal end of the tibia were sig-
nificantly higher in the obese group.
At the midshaft, tibial cortical area
(12%), periosteal circumference
(10%), and endosteal circumfer-
ence (13%)were larger in the obese
group (P .001). There was no sig-
nificant difference in cortical
vBMD and cortical thickness be-
tween the 2 groups. The SSI was
significantly higher (17%) in the
obese group (Table 2).
Comparison of hormonal
parameters between ObAs and
age-matched controls
ObAs have significant higher se-
rum leptin levels (28.3 [17.0–38.9]
vs 2.9 [2.1–5.4] ng/mL; P  .001)
compared with chronological age-
matched controls representative for
their higher fat mass. Median serum
estrogen levels (E2,16.2 [3.7–25.7] vs8.4 [1.7–15.7]ng/L,
P  .01; free E2, 0.32 [0.07–0.54] vs 0.14 [0.02–0.30]
ng/L, P .01; and E1, 22.3 [13–35.6] vs 17.0 [7.6–26.5]
ng/L, P  .03) were markedly higher in the obese group.
Although both testosterone (247 [35–355] vs 407 [81.1–
482] ng/dL, P  .05) and SHBG (2.5 [1.9–4.3] vs 5.5
[4.0–8.9] nmol/L,P .001) levelswere lower in the obese
group, free testosterone levels (5.6 [0.6–9.0] vs 5.7 [0.7–
9.1] ng/dL, NS) were comparable between both groups.
There was no difference in IGF-I levels between the 2
groups (288 [217–412] vs 314 [251–399] ng/mL, NS).
p <0.02 p <0.01
p <0.01
ns ns
Tanner Genital staging Tanner Genital staging
Error bars +/- 1SE
p <0.01
A B
C D
E F
Figure 2. A–F, Trabecular and cortical bone parameters at the radius at different pubertal
stages. The line plots present (from left to right) mean trabecular vBMD (A), mean trabecular area
(B), mean periosteal circumference (C), mean cortical area (D), mean cortical thickness (E), and
mean cortical vBMD (F) for each pubertal stage (prepuberty, 1; postpuberty, 5) for the 2 study
groups. The error bars represent 1 SEM. The obese group is presented by the dashed line and the
age-matched control group by the solid line. The interconnecting lines do not present
longitudinal data.
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As expected,higher sex steroids (E2and testosterone) lev-
elswere foundwithadvancingpubertal development inboth
groups (Figure 1, C and D). Moreover, ObAs had at each
pubertal stagemarkedlyhigherserumestrogenlevels (E2and
E1) comparedwith normal-weight controls (Figure 1, B and
C).Mediantestosterone levels tendedtobe lower intheobese
group at different pubertal stages (Figure 1D).
Comparison of muscle force and muscle mass data
between ObAs and age-matched controls
As shown in Table 3, peak force and peak power in the
single 2-legged jump were, respectively, 43% and 21%
higher in theObAs comparedwith the controls.However,
ObAs jumped on average less high
than the controls, and their maximal
vertical velocity during the takeoff
phase of the jump was lower.
Weight-related peak force and
power were, respectively, 9% and
32% lower than in the controls. In
the multiple 1-legged hopping, peak
force on the left and right side were
35% and 32% higher in the obese
subjects. However, relative to body
weight, these forces were 6% and
11% lower in the obese group than
in the control group.Muscle mass as
well asmuscle forcewashigher in the
obese group at any pubertal stage
(data not shown).
The correlation between E2 and
free E2 and the bone
parameters in the whole
population
Both E2 and free E2 (FE2) corre-
lated by linear regression with tra-
becular vBMD at the radius (E2, ß
0.46, P  .001; FE2, ß  0.47, P 
.001) and tibia (E2, ß  0.51, P 
.001; FE2, ß  0.53, P  .001) and
with cortical area at both sites (ra-
dius: E2, ß 0.70, P .001; FE2, ß
0.50,P .001; tibia: E2, ß0.73,
P .001; FE2, ß 0.73, P .001).
Regressionmodels including age and
BMI showed that E2 and FE2 were
positively associated with trabecular
vBMD at the radius (E2, ß  0.38,
P .05; FE2, ß 0.42, P .01) and
tibia (E2, ß  0.35, P  .05; FE2, ß
 0.37, P .05) and with the corti-
cal area at the radius (E2, ß  0.31,
P  .01; FE2, ß  0.32, P  .01) and the tibia (E2, ß 
0.24, P  .05; FE2, ß  0.23, P  .05). No significant
associations were found between (F)E2 and cortical
vBMD, endosteal circumference, and trabecular area.
Discussion
The present study was undertaken to investigate the
vBMD and bone geometry of the peripheral skeleton in
obese children during late childhood and adolescence.
Our results demonstrate that ObAs have larger and stron-
ger bones at the lower leg (tibia) and to a lesser degree at
100.0<p50.0< p BA
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Figure 3. A–F, Trabecular and cortical bone parameters at the tibia at different pubertal stages. The
line plots present (from left to right) mean trabecular vBMD (A), mean trabecular area (B), mean
periosteal circumference (C), mean cortical area (D), mean cortical thickness (E), and mean cortical
vBMD (F) for each pubertal stage (prepuberty, 1; postpuberty, 5) for the 2 study groups. The error
bars represent 1 SEM. The obese group is presented by the dashed line and the age-matched control
group by the solid line. The interconnecting lines do not present longitudinal data.
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the lower arm (radius) than their normal-weight peers.
Moreover, ObAs show amore advanced bonematuration
in early and midpuberty, have higher circulating estrogen
levels, and develop higher muscle forces at jumping.
As far as we know, only 3 other studies investigated the
effects of obesity on vBMDandbone size inmale children,
but they included principally prepubertal children (10–
12). Because our study group consists mainly of adoles-
cents, our data can contribute to a better understanding of
the effect of obesity on bone geometry andmineralization
in puberty. In contrast, we used both a chronological and
bone age-matched control design to explore the impact of
increased adiposity. Additionally, changes in hormones
involved in bone growth, such as sex steroids and IGF-I, as
well as alterations in muscle mass and force were investi-
gated to explore their potential role in bone development
during adolescence.
Our bone results are in line with the results of Wetzs-
teon et al (10) and Ducher et al (11) who studied only
prepubertal children. Wetzsteon et al (10) described
higher vBMD, bone area, and bone strength parameters at
the tibia in overweight children. These results were con-
firmed by Ducher et al (11), who found a significantly
larger bone size and trabecular density at the forearm and
the lower leg in their overweight group. No difference in
cortical density could be found in either study (10, 11).
Ehehalt et al (12) studied a group of 84 overweight chil-
dren and early adolescents (mean age 12 years) and found
an altered bone structure compared with normal-weight
peers at the radius; bone circumferences were larger,
whereas the cortex was thinner.
By studying bone maturation, hormones, and muscle
force inparallel, our data give theopportunity to speculate
about the different mechanisms that may underlie the ob-
served differences in bone geometry and bone mineraliza-
tion. First, in accordance with previous studies, we found
that up to the age of 16 years,ObAs have amore advanced
bonematuration comparedwith age- and height-matched
controls (19, 29–31). The advanced bone development
might explain at least part of the observed differences in
bone expansion in our study, because after matching for
bone age, no differences in cortical parameters were pres-
ent, at least at the radius. However, most of the geometric
differences at the tibia remained, in favor of the obese
group. These results indicate that advanced bone matu-
ration is probably not the sole explanation for the ob-
served differences in bone geometry between obese and
control boys.We speculate that higher estrogen levels as a
consequence of a higher aromatization rate due to excess
body fat are likely to contribute to the advanced bone mat-
uration in adolescent obesity (29). However, this might not
be the unique explanation because Johnson et al (30) de-
scribed also a more advanced rate of bone maturation
throughout childhood. Some authors suggest that the ad-
vanced bone development in obese children is due to an in-
creased IGF-I production (19). However, we did not find
significant differences in IGF-I levels between young obese
boys and their controls. Our results of normal serum IGF-I
levels are in accordancewith themore recent studies inobese
children and adolescents using similar immunoassays (32,
33), althoughwe cannot exclude that the free IGF-I concen-
trationmight be elevatedas a consequenceof decreased IGF-
I–binding proteins 1 and 2 concentrations and an elevated
IGF-I–binding protein proteolysis in obesity (33).
Second, a larger muscle size and force might play an
important role in a greater bone expansion in adolescent
obesity. Strain frommuscle force is a known major deter-
minantofbone sizeduring childhoodandadolescence (34,
35). Our results confirmed a significantly higher muscle
CSA at the tibia and the radius and a higher muscle force
Table 3. Comparison of Single 2-Legged Jump and Multiple 1-Legged Hopping Between Obese and Normal-Weight
Boys (Matched for Age and Height)
Obese Controls
Significance
Level (P)
Single 2-legged jump
Jumping height, m 0.2 (0.16–0.25) 0.4 (0.38–0.49) .001
Peak force, kN 2.1 (1.5–2.4) 1.2 (1.1–1.6) .001
Peak power, kW 2.9 (2.1–3.7) 2.3 (1.8–3.2) .02
Peak velocity, m/s 2.0 (1.8–2.1) 2.5 (2.2–2.6) .001
Peak force per body weight 2.4 (2.1–2.6) 2.5 (2.2–2.6) .068
Peak power per body weight, W/kg 34.3 (29.5–40.6) 45.0 (40.2–52.4) .001
Multiple 1-legged hopping
Peak force left leg, kN 2.1 (1.7–2.6) 1.4 (1.2–1.8) .001
Peak force right leg, kN 2.0 (1.6–2.5) 1.4 (1.2–1.8) .001
Peak force left leg per body weight 2.5 (2.2–2.7) 2.7 (2.4–3.1) .001
Peak force right leg per body weight 2.5 (2.3–2.7) 2.8 (2.4–3.1) .001
For non-Gaussian distribution, data are presented as median (25th–75th percentile). Comparisons between obese and control group were
performed using Mann-Whitney U tests.
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and power in ObAs. Because muscle mass and force in-
crease throughout puberty togetherwith increases in bone
area, it seems plausible that the larger bones and increased
bone strength in ObAs, after correction for bone age, are
caused by the higher mechanical load applied to the skel-
eton, not only through a greater body weight but also by
an increased muscle mass and force. This is supported in
our study by the observation of more distinct differences
in bone geometry at the tibia, aweight-bearing bone, com-
pared with the radius, a non–weight-bearing bone. These
features are consistent with the results of some other stud-
ies. In obese children, Ducher et al (11) described a higher
muscle CSA both at the tibia and at the radius and Rauch
et al (36) documented a higher peakmuscle force and peak
power. More support for this view comes from a recent
longitudinal study in overweight children showing that
increases in bone size and strength were related to the
larger muscle mass but not fat mass (10). These findings
support themechanostat theory of Frost (34) and the con-
cept that bones adapt primarily to dynamic forces pro-
duced by muscle contractions (37, 38) and not to static
forces imposed by extra fat mass.
Finally, we hypothesized that hormonal changes re-
lated to obesity could be involved in a different bone de-
velopment and bone mass accrual during puberty. Obese
adolescents in our study had at the different pubertal
stages higher E2 and E1 levels, which were determined
using a state-of-the-art liquid chromatography tandem
mass spectrometry-based methodology. It can be noted
that the difference in serum E2 is even greater when con-
sidering FE2 as a consequence of lower SHBG concentra-
tions. Only 1 other study addressed the influence of sex
steroids on BMD in obese children. In contrast to our
study, no differences in circulating estrogen levels and a
similar aBMDwere found in this study (29). Both the low
number of adolescents studied and the use of an immu-
noassay known to have a limited reliability for measuring
low levels of E2 might be responsible for not finding a
difference in circulating estrogens in this particular study.
To study the influence of E2 on different bone compart-
ments, well-described determinants of bonemass were as-
sessed using linear regression. We observed a positive as-
sociation between (F)E2 and trabecular vBMD at the
radius and the tibia aswell as anassociationbetween (F)E2
and cortical area at the radius and tibia.
To our knowledge, this is the first matched-control
study to report data on volumetric bone parameters and
bone geometry of the tibia and the radius in adolescent
obesity. The strength of the present study is the compre-
hensive evaluation of bone geometry,muscle strength, pu-
bertal development, and hormonal factors (especially es-
trogens) involved in bone expansion. Although the
important role of estrogens in bone homeostasis is gener-
ally acknowledged, this study is the first to look for a
relationshipbetween circulating total and free estrogens in
amixed obese and lean adolescent population.Moreover,
in this study, sex steroids were measured by highly sensi-
tive and accurate mass spectrometry-based methodology
as required when studying low androgen and estrogen
serum levels in children and adolescents. Our study is lim-
ited by the fact that we have assessed only cross-sectional
data. To confirm and further unravel underlying mecha-
nisms, prospective longitudinal studies are required, ide-
ally with follow-up from early childhood at onset of obe-
sity until adulthood.
Conclusion
We observed at both forearm and lower leg larger and
stronger bones in ObAs compared with normal-weight
peers. These differences in bone development can be ex-
plained by a combination of advanced bone maturation,
higher estrogen exposure, and higher mechanical loading
resulting from a greater muscle mass and strength.
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